| Saldivar Home Health Inc | |
| 618 Bluebonnet St, Alice, Texas 78332 | |
| (361) 396-1204 | |
| Not Available |
| Name | Saldivar Home Health Inc |
|---|---|
| Location | 618 Bluebonnet St, Alice, Texas |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 457865 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 78022, 78332, 78357, 78363, 78372, 78380, 78383, 78384, 78410, 78415 |
| NPI Number | 1407277478 |
| Organization Name | SALDIVAR, INC. |
| Doing Business As | SALDIVAR HOME HEALTHCARE |
| Address | 905 N Johnson St, Alice, TX 78332 |
| Phone Number | 361-396-1200 |
News Archive
A drug which was originally developed to treat leukaemia and other cancers of the immune system offers substantial improvements over existing treatments in reducing relapse rates for people with multiple sclerosis (MS), even when they have not responded well to first-line treatment, according to the results of two phase 3 trials published Online First in The Lancet.
NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced that it closed a private placement financing with institutional and other accredited investors, including members of NewCardio's management team and board of directors, who purchased over half of the offering.
The Boston Globe: "US officials have asked some AIDS clinics overseas to stop enrolling new patients in a US-sponsored program that provides lifesaving antiretroviral drugs" in an effort to stem the rising costs of this assistance program. This step has triggered concern among some AIDS advocates "that the Obama administration is curtailing its commitment to a program that provides lifesaving drugs for 2.4 million people and that many view as President Bush's most successful foreign policy legacy.
Eisai Co., Ltd. and Biogen Idec announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401.
In this post in Global Post's "Global Pulse" blog, Mitchell Warren, executive director of AVAC, a leading HIV prevention advocacy organization, and Chris Collins, vice president and director of public policy at amfAR, the Foundation for AIDS Research, write that "the world needs a business plan to end AIDS."
› Verified 7 days ago
| NPI Number | 1437109675 |
| Organization Name | SALDIVAR HOME HEALTH, INC. |
| Address | 905 N Johnson St, Alice, TX 78332 |
| Phone Number | 361-396-1204 |
News Archive
A drug which was originally developed to treat leukaemia and other cancers of the immune system offers substantial improvements over existing treatments in reducing relapse rates for people with multiple sclerosis (MS), even when they have not responded well to first-line treatment, according to the results of two phase 3 trials published Online First in The Lancet.
NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced that it closed a private placement financing with institutional and other accredited investors, including members of NewCardio's management team and board of directors, who purchased over half of the offering.
The Boston Globe: "US officials have asked some AIDS clinics overseas to stop enrolling new patients in a US-sponsored program that provides lifesaving antiretroviral drugs" in an effort to stem the rising costs of this assistance program. This step has triggered concern among some AIDS advocates "that the Obama administration is curtailing its commitment to a program that provides lifesaving drugs for 2.4 million people and that many view as President Bush's most successful foreign policy legacy.
Eisai Co., Ltd. and Biogen Idec announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401.
In this post in Global Post's "Global Pulse" blog, Mitchell Warren, executive director of AVAC, a leading HIV prevention advocacy organization, and Chris Collins, vice president and director of public policy at amfAR, the Foundation for AIDS Research, write that "the world needs a business plan to end AIDS."
› Verified 7 days ago
| Quality Rating: | Not Available* |
| * The number of patient episodes for this measure is too small to report. | |
News Archive
A drug which was originally developed to treat leukaemia and other cancers of the immune system offers substantial improvements over existing treatments in reducing relapse rates for people with multiple sclerosis (MS), even when they have not responded well to first-line treatment, according to the results of two phase 3 trials published Online First in The Lancet.
NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced that it closed a private placement financing with institutional and other accredited investors, including members of NewCardio's management team and board of directors, who purchased over half of the offering.
The Boston Globe: "US officials have asked some AIDS clinics overseas to stop enrolling new patients in a US-sponsored program that provides lifesaving antiretroviral drugs" in an effort to stem the rising costs of this assistance program. This step has triggered concern among some AIDS advocates "that the Obama administration is curtailing its commitment to a program that provides lifesaving drugs for 2.4 million people and that many view as President Bush's most successful foreign policy legacy.
Eisai Co., Ltd. and Biogen Idec announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401.
In this post in Global Post's "Global Pulse" blog, Mitchell Warren, executive director of AVAC, a leading HIV prevention advocacy organization, and Chris Collins, vice president and director of public policy at amfAR, the Foundation for AIDS Research, write that "the world needs a business plan to end AIDS."
› Verified 7 days ago
News Archive
A drug which was originally developed to treat leukaemia and other cancers of the immune system offers substantial improvements over existing treatments in reducing relapse rates for people with multiple sclerosis (MS), even when they have not responded well to first-line treatment, according to the results of two phase 3 trials published Online First in The Lancet.
NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, today announced that it closed a private placement financing with institutional and other accredited investors, including members of NewCardio's management team and board of directors, who purchased over half of the offering.
The Boston Globe: "US officials have asked some AIDS clinics overseas to stop enrolling new patients in a US-sponsored program that provides lifesaving antiretroviral drugs" in an effort to stem the rising costs of this assistance program. This step has triggered concern among some AIDS advocates "that the Obama administration is curtailing its commitment to a program that provides lifesaving drugs for 2.4 million people and that many view as President Bush's most successful foreign policy legacy.
Eisai Co., Ltd. and Biogen Idec announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401.
In this post in Global Post's "Global Pulse" blog, Mitchell Warren, executive director of AVAC, a leading HIV prevention advocacy organization, and Chris Collins, vice president and director of public policy at amfAR, the Foundation for AIDS Research, write that "the world needs a business plan to end AIDS."
› Verified 7 days ago
Real Home Health Care Inc Location: 301 Lucero Street, Alice, Texas 78332 Ratings: NA Phone: (361) 668-3158 | |
Saldivar Home Health Inc Location: 618 Bluebonnet St, Alice, Texas 78332 Ratings: NA Phone: (361) 396-1204 | |
Del Cielo Home Care Services Location: 601 E Main St Suite 300, Alice, Texas 78332 Ratings: Phone: (361) 664-3484 | |
Carestat Provider Services Location: 171 Medical Center Blvd Unit D, Alice, Texas 78332 Ratings: Phone: (361) 241-4600 | |
Healthy Horizons Homecare Llc Location: 1006 E 6th St, Alice, Texas 78332 Ratings: Phone: (361) 396-1282 |